Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Prioritizing antiretrovirals for second-line therapy in resource-limited countries.

Naidoo K.

AIDS Clin Care. 2008 May;20(5):43. No abstract available.

PMID:
19230296
2.

COMMENTARY: understanding the benefits of pediatric anti-retroviral treatment in resource-limited settings.

Hetherington S.

Pediatr Infect Dis J. 2009 Jan;28(1):41-2. doi: 10.1097/INF.0b013e318184ef4c.

PMID:
19057455
3.

When to switch for antiretroviral treatment failure in resource-limited settings?

Vekemans M, John L, Colebunders R.

AIDS. 2007 May 31;21(9):1205-6. No abstract available.

PMID:
17502731
4.

HIV drug resistance.

Calmy A, Pascual F, Ford N.

N Engl J Med. 2004 Jun 24;350(26):2720-1. No abstract available.

5.

The World Health Organization's global strategy for prevention and assessment of HIV drug resistance.

Bennett DE, Bertagnolio S, Sutherland D, Gilks CF.

Antivir Ther. 2008;13 Suppl 2:1-13.

PMID:
18578063
6.

The marriage of science and optimized HIV care in resource-limited settings.

Calmy A, Pizzocolo C, Pizarro L, Brücker G, Murphy R, Katlama C; Strategies in Resource-Limited Settings Working Group..

AIDS. 2008 Nov 12;22(17):2227-30. doi: 10.1097/QAD.0b013e32830f4c4d. No abstract available.

PMID:
18981761
7.

Antiretroviral therapy in resource-poor settings: scaling up inequalities?

Egger M, Boulle A, Schechter M, Miotti P.

Int J Epidemiol. 2005 Jun;34(3):509-12. No abstract available.

PMID:
15941732
8.

Management of antiretroviral failure and resistance in developing countries.

Hawkins C, Murphy RL.

Curr Opin HIV AIDS. 2009 Nov;4(6):538-44. doi: 10.1097/COH.0b013e328331d2fb.

PMID:
20048723
9.

Simplifying and adapting antiretroviral treatment in resource-poor settings: a necessary step to scaling-up.

Calmy A, Klement E, Teck R, Berman D, Pécoul B, Ferradini L.

AIDS. 2004 Dec 3;18(18):2353-60. Review. No abstract available.

PMID:
15622311
10.

World Bank meeting concludes drug resistance should not prevent distribution of antiretroviral therapy to poor countries.

Kuritzkes D, Lange J, Zewdie D.

Nat Med. 2003 Nov;9(11):1343-4. No abstract available.

PMID:
14595419
11.

The obligation to provide antiretroviral treatment in HIV prevention trials.

Lo B, Padian N, Barnes M.

AIDS. 2007 Jun 19;21(10):1229-31.

PMID:
17545698
12.

Continued correspondence 'Will ART rollout in Africa drive an epidemic of drug-resistant HIV?'.

Hastings IM, Lalloo DG, Khoo SH.

AIDS. 2007 Jan 11;21(2):258-9; author reply 259-60. No abstract available.

PMID:
17197825
13.

Antiretroviral treatment strategies in resource-limited settings.

Person AK, Ramadhani HO, Thielman NM.

Curr HIV/AIDS Rep. 2007 May;4(2):73-9. Review.

PMID:
17547828
14.

Antiretroviral therapy programmes in resource limited settings.

del Rio C, Armstrong W.

BMJ. 2011 Nov 9;343:d6853. doi: 10.1136/bmj.d6853. No abstract available.

PMID:
22074712
15.

Current world literature.

[No authors listed]

Curr Opin HIV AIDS. 2010 May;5(3):261-3. doi: 10.1097/COH.0b013e3283390e99. No abstract available.

PMID:
20539084
16.

Clinton brokers deal to lower price of antiretrovirals.

Abimbola S.

BMJ. 2007 May 19;334(7602):1026. No abstract available.

17.

Combining evidence for access to and benefits from antiretroviral treatment to inform planning.

Editorial Steering Committee., Marlink R, Forsythe S, Bertozzi SM, Muirhead D, Holmes M, Sturchio J.

AIDS. 2008 Jul;22 Suppl 1:S121-2. doi: 10.1097/01.aids.0000327632.08093.bd. No abstract available.

PMID:
18664943
18.

Initiating antiretrovirals in a resource-constrained setting: does one size fit all?

Wanchu A.

MedGenMed. 2005 Aug 8;7(3):67. No abstract available.

19.

Preventing HIV transmission with antiretrovirals.

De Cock KM, Crowley SP, Lo YR, Granich RM, Williams BG.

Bull World Health Organ. 2009 Jul;87(7):488-488A. No abstract available.

20.

Antiretroviral treatment in low-resource settings: what has changed in the last 10 years and what needs to change in the coming years?

Mehta M, Semitala F, Lynen L, Colebunders R.

Expert Rev Anti Infect Ther. 2012 Nov;10(11):1287-96. doi: 10.1586/eri.12.129. Review.

PMID:
23241186

Supplemental Content

Support Center